ACMI
PFE icon

Amida Capital Management II’s Pfizer PFE Stock Holding History

Amida Capital Management II’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-799
Closed -$21K – 199
2013
Q2 		$21K Buy
+799
New +$22.1K 0.01% 209

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Amida Capital Management II's PFE Position: Q3 2013 in Review

Amida Capital Management II sold out of Pfizer (PFE) in Q3 2013, closing a stake of 799 shares — an estimated $21K sold.

Amida Capital Management II first reported a position in PFE in Q2 2013 and held it in 1 quarter. The position peaked at $21K in Q2 2013. 1,606 funds tracked by Wall St. Rank hold PFE as of Q3 2013.

  • Amida Capital Management II reported no remaining Pfizer position as of Q3 2013 after selling out during the quarter.
  • Amida Capital Management II sold 799 Pfizer shares in Q3 2013, an estimated $21K.
  • Amida Capital Management II first reported a position in Pfizer in Q2 2013 and held it in 1 quarter.
  • Amida Capital Management II's Pfizer position peaked at $21K in Q2 2013.
  • 1,606 funds tracked by Wall St. Rank held Pfizer as of Q3 2013.

Based on Amida Capital Management II's 13F filing for Q3 2013, filed 13 Nov 2013.